60 F
New York
Friday, May 7, 2021

Takeda [NYSE: TAK] Decides To Sell Japanese Consumer Health Unit For $2.3B

Must read

Coinbase Pro Announces it will be Listing Internet Computer’s ICP

Coinbase Pro cryptocurrency exchange has disclosed that it has decided to list ICP once it goes live. ICP is the governance token of the...

WISeKey [NASDAQ: WKEY] Gets Investment to finance its TrustNFT.IO NFT Platform

WISeKey International Holding AG disclosed Friday that it has inked a term-sheet to enter into an unsecured short-term loan and the issuance and...

Moderna [NASDAQ: MRNA] Inks Supply Agreement with Switzerland

Moderna, Inc. disclosed that it has inked a supply agreement on Thursday with the Swiss Federal Government. As per the agreement, Moderna Inc...

TeraBlock Will Have its Own BSCPad IDO Soon

TeraBlock which is a project making a platform for automated cryptocurrency portfolio management disclosed that it is preparing for an initial DEX offering (IDO)...

Takeda Pharmaceutical Company Limited [NYSE: TAK] has decided to sell its Japanese Consumer Health Unit to US investment fund Blackstone Group for $2.3 billion.

Blackstone Group is one of the world-leading investment firm. Its experience in the health care sector is high. The deal is expected to close by March 31, 2021.

Shares of Takeda Pharmaceutical has dropped 0.37% or down -0.07 cents during the trading of Friday. It has earlier opened at 18.86 and has a closing price of $18.84.

Takeda has a day low range of $18.74 a high range of $18.91. It has a trading volume of 826.72K as compared to the average volume of 1.07 million.

TAK has a 52-weeks low range of $12.43 and a day high range of $20.92. It has moved up 51.57% from its 52-weeks low and moved down-9.96% from its 52-weeks low. Takeda has a total market capitalization of 59.40 billion.

The portfolio which is to be sold to Blackstone includes a variety of over-the-counter (OTC) medicines and health products that generated total revenues of over 60 billion in the fiscal year.

TCHC’s strong regional brands include Alinamin, its top-selling product and Japan’s first vitamin B1 preparation, and Benza, a cold remedy. Blackstone aims to pursue its business with current TCHC management.

Takeda has laid the foundation of TCHC in April 2017 to further grow the consumer health care business in Japan. Now its aim is to focus on highly innovative medicines across its five key business areas.

More articles

Latest article

Why Chiasma [NASDAQ: CHMA] Stock is Skyrocketed?

Shares of Chiasma, Inc. surged 46.48% during the trading session of Wednesday. Chiasma has disclosed the financial results for the Q1 completed March...

NeoGenomics [NASDAQ: NEO] Announces Acquisition of Inivata Ltd

NeoGenomics, Inc. revealed Wednesday that it has decided to purchase Inivata Ltd. Inivata will grow into a liquid biopsy-centered division together with increasing...

R1 RCM [NASDAQ: RCM] Announces Acquisition of VisitPay

R1 RCM Inc. disclosed Tuesday that it has decided to purchase VisitPay. The firm has inked an agreement to buy VisitPay for nearly...

Binance Coin Makes History as its Market Cap Reach $100 Billion

The market capitalization of Binance set new records as the exchange token of Binance and the native asset of Binance Smart Chain (BSC) touched...

Precipio [NASDAQ: PRPO] Roll Out Rapid COVID-19 Antibody test on Amazon Platform

Shares of Precipio, Inc. skyrocketed 40.35% during the trading session of Monday. The strong performance of the firm has highlighted the positive sentiments...

TechX Ink Deal to Buy Fiat-to-Crypto Merchant Services Gateway XPort Digital

TechX Technologies Inc disclosed Monday that it has bought fiat-to-crypto merchant services gateway XPort digital. The firm has bought a 100% stake in XPort...

Lockheed [NYSE: LMT] Present F-35 Best and Final Offer to Finnish Government

Lockheed Martin Corporation disclosed that it has presented F-35 best and final offer (BAFO) on April 29, 2021, to the Finnish government. It...

Clene [NASDAQ: CLNN] Gets Two Patent Notice of Allowances

Clene Inc. disclosed that Clene Nanomedicine, Inc. U.S. Patent and Trademark Office has provided Notices of Allowance for two significant patent applications. Clene...